How patches made from human placenta could save men's love lives
Patches made from human placenta could prevent men becoming impotent following prostate cancer surgery. Incontinence and erectile dysfunction can occur in up to seven in ten men. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2020 Category: Consumer Health News Source Type: news

Bloomberg Said U.S. Should Deny Treatment To Old People With Chronic Disease
If Democratic Presidential candidate Mike Bloomberg was 95 years old and had prostate cancer, he could afford extreme medical care to improve and extend his life. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 17, 2020 Category: Pharmaceuticals Authors: Patricia Barnes, Contributor Source Type: news

Suicide risk among prostate cancer patients before and after the implementation of prostate-specific antigen-based prostate screening in Lithuania in 2006 - Patasius A, Kaceniene A, Ulys A, Stukas R, Smailyte G.
Despite good prognosis, increased suicide rates are reported for prostate cancer. The aim of this study was to assess the risk of suicide among prostate cancer patients before and after the start of nation-wide prostate-specific antigen (PSA)-based screeni... (Source: SafetyLit)
Source: SafetyLit - February 16, 2020 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Cholesterol Drugs Might Help Curb Prostate Cancers
The study couldn't prove cause and effect, but it found that statins, taken alone or with metformin, did seem associated with an increase in survival. (Source: WebMD Health)
Source: WebMD Health - February 14, 2020 Category: Consumer Health News Source Type: news

A Rare QoL Study That Could Change Practice A Rare QoL Study That Could Change Practice
Two drugs comparably improve survival in the treatment of men with hormone-sensitive prostate cancer, so researchers looked at quality of life to see whether that was a difference maker.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cholesterol Drugs Might Help Curb ‘ High - Risk ’ Prostate Cancers
(Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - February 14, 2020 Category: Reproduction Medicine Tags: Cardiology, Oncology, Pharmacy, Reproductive Medicine, Diabetes, News, Source Type: news

Cholesterol Drugs Might Help Curb'High-Risk' Prostate Cancers
FRIDAY, Feb. 14, 2020 -- Drugs that many men with prostate cancer might already be taking -- cholesterol-lowering statins -- may help extend their survival if they have a " high-risk " form of the disease, new research suggests. High-risk patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2020 Category: General Medicine Source Type: news

Cholesterol Drugs Might Help Curb 'High-Risk' Prostate Cancers
Title: Cholesterol Drugs Might Help Curb 'High-Risk' Prostate CancersCategory: Health NewsCreated: 2/14/2020 12:00:00 AMLast Editorial Review: 2/14/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 14, 2020 Category: Cancer & Oncology Source Type: news

Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
SAN DIEGO, Feb. 13, 2020 -- (Healthcare Sales & Marketing Network) -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers, today announced that a Decipher GRID mole... Diagnostics, Oncology Decipher Biosciences, Decipher GRID, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2020 Category: Pharmaceuticals Source Type: news

Prostate cancer symptoms: Toilet troubles could signal the deadly disease
PROSTATE cancer is the most common cancer to affect British men. With early warning signs hard to come by, make sure you're aware of the troubling symptoms that could appear when the tumour grows larger. (Source: Daily Express - Health)
Source: Daily Express - Health - February 13, 2020 Category: Consumer Health News Source Type: news

Taming hormones with food: physician resolves infertility, diabetes, & other conditions
(Physicians Committee for Responsible Medicine) Nutrition researcher and New York Times bestselling author Neal Barnard, MD, demonstrates how foods affect our hormones--and our health--in his new book, Your Body in Balance. Dr. Barnard shares the science behind how common conditions--like infertility, weight gain, menopausal symptoms, breast and prostate cancers, thyroid problems, and acne--are fueled by hormones that are hidden in or influenced by the foods we eat. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 13, 2020 Category: Biology Source Type: news

Researchers validate link between genetic variant and poor outcomes in advanced prostate cancer
(Cleveland Clinic) In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that a testosterone-related genetic variant -- HSD3B1(1245C) -- is associated with more aggressive disease and shorter survival in men with metastatic prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 13, 2020 Category: Cancer & Oncology Source Type: news

Stereotactic Body Radiotherapy Use in Prostate Cancer
Researchers in this study found that though SBRT use more than doubled from 2010 to 2015 in patients with prostate cancer, it only accounted for less than 10% of all patients undergoing radiotherapy. (Source: CancerNetwork)
Source: CancerNetwork - February 12, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

PIONEER milestone - First two datasets uploaded into the PIONEER Big Data platform
(European Association of Urology) In an important step forward the first datasets have been transferred into the PIONEER Big Data platform by PIONEER partner Erasmus University Medical Centre (MC). Through the application of Big Data and the analyses of real-world evidence PIONEER aims to change the prostate cancer landscape to improve the health and social care received by all prostate cancer patients and their families. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 11, 2020 Category: Cancer & Oncology Source Type: news

Testosterone Has Different Effect in Men and Women
In women, testosterone may increase the risk for type 2 diabetes, while in men it lowers that risk. But high levels of testosterone increase the risk for breast and endometrial cancer in women and prostate cancer in men, the researchers reported. (Source: WebMD Health)
Source: WebMD Health - February 10, 2020 Category: Consumer Health News Source Type: news

Statins may lower mortality in high-risk prostate cancer patients
(Thomas Jefferson University) Statin use alone or with metformin is associated with lower prostate cancer mortality from all causes, among high-risk patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

The benefits of physical activity for older adults
(Wiley) New findings published in the Scandinavian Journal of Medicine& Science in Sports reveal how physically active older adults benefit from reduced risks of early death, breast and prostate cancer, fractures, recurrent falls, functional limitations, cognitive decline, dementia, Alzheimer's disease, and depression. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 5, 2020 Category: International Medicine & Public Health Source Type: news

With Equal Access to Care, Blacks, Whites Have Similar Prostate Cancer Outcomes
MONDAY, Feb. 3, 2020 -- Survival rates are similar for black and white prostate cancer patients who are treated in an equal-access health system, researchers say. In the general U.S. population, black men are more likely than white men to be... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 3, 2020 Category: General Medicine Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Research Suggests Repeated Screening in Men with Prostate Cancer Can Be Less Frequent
This study found that men with low baseline PSA levels could be screened less frequently, while men with higher baseline levels would benefit from more intensive screening strategies. (Source: CancerNetwork)
Source: CancerNetwork - February 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Prostate cancer symptoms: Signs to look out for during sex that may signal the condition
PROSTATE cancer symptoms don't usually appear until the cancer has advanced, which is why recognising signs when they develop is very important. Certain signs of the condition may appear when a person has sex. (Source: Daily Express - Health)
Source: Daily Express - Health - February 2, 2020 Category: Consumer Health News Source Type: news

Proportion and Incidence of Prostate Cancer May Increase with Age
Given these data, the researchers indicated that physicians screening for this cancer type should account for strong age dependence. (Source: CancerNetwork)
Source: CancerNetwork - February 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Darolutamide (Nubeqa) Gets OK in Europe for Prostate Cancer Darolutamide (Nubeqa) Gets OK in Europe for Prostate Cancer
It joins two other androgen receptor inhibitors for use in the treatment of nonmetastatic castration-resistant prostate cancer.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling pro
(Impact Journals LLC) In addition to 4 reported PMEPA1 isoforms, one novel isoform PMEPA1-e was identified with RNA Seq analysis of hormone-responsive VCa P, LNCa P cells and human prostate cancer samples from The Cancer Genome Atlas dataset. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 31, 2020 Category: Cancer & Oncology Source Type: news

Inherited DNA-repair gene mutations in African American men with prostate cancer
(Impact Journals LLC) Oncotarget Volume 11, Issue 4: Pathogenic or likely pathogenic alterations in these 14 DNA repair genes were less likely to be detected in African Americans as compared to Caucasians. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 31, 2020 Category: Cancer & Oncology Source Type: news

Phase III ARAMIS Trial Showed Significant Improvement in OS for Patients with Prostate Cancer
The investigation of darolutamide plus ADT in men with non-metastatic castration-resistant prostate cancer indicated a significant improvement in overall survival in this patient population. (Source: CancerNetwork)
Source: CancerNetwork - January 31, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Upstate now using revolutionary hydrogel to protect organs during radiation for prostate cancer
Inserted as a liquid, the solidified gel moves the prostate away from other organs. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - January 30, 2020 Category: Universities & Medical Training Tags: News Source Type: news

Darolutamide plus androgen deprivation therapy significantly increased overall survival in men with non-metastatic castration-resistant prostate cancer (for specialized target groups only)
Full data to be presented at upcoming scientific meeting (Source: Bayer Company News)
Source: Bayer Company News - January 30, 2020 Category: Pharmaceuticals Source Type: news

UPenn scientists receive ACGT grant to accelerate CAR T-Cell clinical trial
(Alliance for Cancer Gene Therapy) Alliance for Cancer Gene Therapy awards grant to University of Pennsylvania scientists to use CAR T-cell gene therapy to treat advanced metastatic prostate cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2020 Category: International Medicine & Public Health Source Type: news

Nigeria: Why Older Men Need to Be Informed About Prostate Cancer - Experts
[Premium Times] Men 50 years and above or those with a family history of prostate cancer need to know the early symptoms of the disease so that they can present themselves early for treatment, a health expert, Musliu Tolani has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 29, 2020 Category: African Health Source Type: news

Ghana: Prostate Cancer Awareness--the Need for Celebrities/Public Figures to Support the Campaign
[Ghanaian Times] A story in the health section of the BBC caught my attention yesterday. It was filed by the BBC health editor named Michelle Roberts. The story said that Prostate cancer, the most commonly diagnosed cancer in the United Kingdom has now overtaken breast cancer. There were 50,000 registered cases of prostate cancer cases in England, a figure about 8,000 more than was seen in 2017. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 29, 2020 Category: African Health Source Type: news

NCRI welcomes Prostate Cancer Research Centre as new partner
(National Cancer Research Institute) The National Cancer Research Institute (NCRI) is pleased to announce that Prostate Cancer Research Centre (PCRC) have recently joined as a partner. Prostate Cancer Research Centre aims to fund research that will develop effective treatments and better our understanding of prostate cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2020 Category: International Medicine & Public Health Source Type: news

Bluestar Genomics ’ breakthrough study highlights promising data for multi-cancer detection from a single blood draw
(CG Life) Bluestar Genomics published a new study demonstrating the efficacy of their 5-hydroxymethylcytosine (5hmC) signal detection technology for its use in breast, lung, pancreatic, and prostate cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 29, 2020 Category: Biology Source Type: news

New inhibitor shows promise against metastatic prostate cancer
(Stony Brook University) When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2020 Category: Cancer & Oncology Source Type: news

Equal Access HealthCare May Improve Survival Outcomes Among Men with Prostate cancer
A study of the Veterans Affairs health system found that, despite trends suggesting otherwise, African American men with prostate cancer had similar survival outcomes, compared with non-Hispanic white men. (Source: CancerNetwork)
Source: CancerNetwork - January 29, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news

Prostate cancer symptoms: This sensation when urinating could signal the deadly disease
PROSTATE cancer cases have seen a major surge in the last few years. With the worrying amount of new cases, knowing and recognising the early warning signs is crucial. If a person feels a certain sensation when urinating it should not be ignored. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - January 28, 2020 Category: Consumer Health News Source Type: news

Outcomes No Worse for Black Veterans With Prostate Cancer
For men in VA health system, blacks do not present with more advanced disease or have higher mortality (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 27, 2020 Category: Cancer & Oncology Tags: Internal Medicine, Oncology, Urology, Journal, Source Type: news

9/11 Workers May Be at Higher Cancer Risk
Ground zero workers had higher rates of cancer, especially prostate and thyroid cancers and leukemia. (Source: NYT Health)
Source: NYT Health - January 27, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: World Trade Center (Manhattan, NY) Cancer Prostate Cancer Thyroid Cancer Leukemia Mount Sinai Medical Center Source Type: news

Access to Care May Explain Disparities in Prostate Cancer Outcomes
Disparities in medical care may account for why African-American men with prostate cancer are almost twice as likely to die as white men with the disease. (Source: NYT Health)
Source: NYT Health - January 27, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Black People Prostate Cancer Race and Ethnicity Prostate Gland Source Type: news

ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and efficacy when the vaccine is used in combination with standard-of-care chemotherapy for patients with inoperable pleural mesothelioma. Targovax, a Scandinavian pharmaceutical company developing the drug, is moving forward with another study combining ONCOS-102 with a checkpoint inhibitor drug such as Keytruda (pembrolizumab) or Opdivo (nivolumab), along with chemotherapy. “We have seen enough data at this point to be going ...
Source: Asbestos and Mesothelioma News - January 27, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Outcomes No Worse for Black Veterans With Prostate Cancer
MONDAY, Jan. 27, 2020 -- For men diagnosed with prostate cancer in the Veterans Affairs health system, African-Americans (AAs) do not present with more advanced disease or have worse outcomes compared with non-Hispanic whites (NHWs), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2020 Category: Pharmaceuticals Source Type: news

Cost of health care remains blurry despite new rules, UNC study finds
Beyond simply being discontent about the high cost of health care in the nation, consumers remain in the dark over what that cost may be – even for a standard treatment for prostate cancer, according to a study out of UNC-Chapel Hill. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2020 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

Study reveals similar survival of African-American and white men with prostate cancer in an equal-access health care system
(Wiley) Among men with prostate cancer who received care from the Veterans Affairs (VA) Health System, an equal-access health care system, African-American men did not have more advanced disease at the time of diagnosis or die earlier than white men, unlike trends seen in the greater US population of patients with prostate cancer. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 27, 2020 Category: Cancer & Oncology Source Type: news

Study examines prostate cancer treatment decisions
(Vanderbilt University Medical Center) A five-year follow-up study of more than 2,000 US men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 27, 2020 Category: Cancer & Oncology Source Type: news

Single PSA Test May Reveal Long-Term Prostate-Cancer Risk Single PSA Test May Reveal Long-Term Prostate-Cancer Risk
Baseline prostate-specific antigen (PSA) levels in midlife are associated with the subsequent risk of clinically significant prostate cancer, according to a secondary analysis of a large clinical trial.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 27, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Anterior-Dominant Prostate Cancer Harder to Detect Than Other Locations Anterior-Dominant Prostate Cancer Harder to Detect Than Other Locations
Anterior-dominant prostate cancer is harder to detect and presents with higher prostate-specific antigen (PSA) levels than prostate cancer in other locations, according to a database study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 23, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Eating More Veggies Won't Stop Prostate Cancer: Study
Title: Eating More Veggies Won't Stop Prostate Cancer: StudyCategory: Health NewsCreated: 1/22/2020 12:00:00 AMLast Editorial Review: 1/23/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 23, 2020 Category: Cancer & Oncology Source Type: news

Bayer receives approval for darolutamide in Japan (for specialized target groups only)
Marketing authorization granted for the treatment of men with non-metastatic castration-resistant prostate cancer (Source: Bayer Company News)
Source: Bayer Company News - January 23, 2020 Category: Pharmaceuticals Source Type: news

Eating More Veggies Won't Stop Prostate Cancer: Study
After two years of follow-up, the group on the vegetable-rich diet saw no extra protection against prostate cancer compared to the control group, according to findings published Jan. 14 in the Journal of the American Medical Association. (Source: WebMD Health)
Source: WebMD Health - January 22, 2020 Category: Consumer Health News Source Type: news

Harms From Prostate Cancer Tx Persist at 5 Years Harms From Prostate Cancer Tx Persist at 5 Years
Changes in urinary, bowel, and sexual function following treatment of prostate cancer diminish over time, but some persist 5 years later.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news